Composition comprising viscous fibers and viscosity-lowering proteins

Details for Australian Patent Application No. 2003242692 (hide)

Owner Novartis AG

Inventors Beer, Michael; Auriou, Nicolas

Agent Davies Collison Cave

Pub. Number AU-B-2003242692

PCT Number PCT/EP03/06194

PCT Pub. Number WO2003/105882

Priority 0213612.5 13.06.02 GB

Filing date 12 June 2003

Wipo publication date 31 December 2003

Acceptance publication date 1 March 2007

International Classifications

A23L 1/308 (2006.01) Foods or foodstuffs - Addition of substantially indigestible substances, e.g. dietary fibres

A23J 3/30 (2006.01) Working-up of proteins for foodstuffs

A23L 1/05 (2006.01) Foods or foodstuffs - containing gelling or thickening agents

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61K 31/715 (2006.01) - Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages

A61K 31/723 (2006.01)

A61K 31/731 (2006.01) - Carrageenans

A61K 31/732 (2006.01) - Pectin

A61K 31/736 (2006.01) - Glucomannans or galactomannans, e.g locust bean gum, guar gum

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 38/39 (2006.01) Medicinal preparations containing peptides - Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin (CIG)

A61K 47/36 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Polysaccharides

A61K 47/42 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Proteins

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

11 September 2003 Complete Application Filed

  Priority application(s): 0213612.5 13.06.02 GB

26 February 2004 Application Open to Public Inspection

  Published as AU-B-2003242692

27 January 2005 Assignment before Grant

  Novartis Nutrition AG The application has been assigned to Novartis AG

1 March 2007 Application Accepted

  Published as AU-B-2003242692

28 June 2007 Standard Patent Sealed

22 January 2009 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 19 Nov 2008. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000

29 January 2009 Assignment Registered

  Novartis AG The patent has been assigned to Nestec S.A.

4 June 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 19 Nov 2008 2004

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003242693-BLUE EMITTING TRIS (8-OXOQUINOLINE) ALUMINUM (III) (AlQ3)

2003242691-POSITIVE-DISPLACEMENT PUMP AND A DEVICE COMPRISING THIS POSITIVE-DISPLACEMENT PUMP FOR DOSING AT LEAST ONE FREEFLOWING CONSTITUENT